The LifeSphere® Platform
Powered by Nava
LifeSphere is an end-to-end life sciences platform, using ArisGlobal’s proprietary Nava® cognitive computing engine to automate all core functions of the drug development process. Offering simple integration with our next-generation LifeSphere EasyDocs document management solution across the product lifecycle, the LifeSphere platform helps life sciences companies reduce time to market, increase compliance and lower drug development costs.
LifeSphere®
Clinical Development
LifeSphere®
Regulatory
LifeSphere®
Safety
LifeSphere®
Medical Affairs
LifeSphere®
Quality
LifeSphere®
EasyDocs
seamlessly woven into the entire LifeSphere ecosystem.
The LifeSphere® Platform
Powered by Nava
LifeSphere is an end-to-end, cloud-based software platform, using ArisGlobal’s proprietary Nava® cognitive computing engine to automate all core functions of the drug development process. Offering simple integration with our next-generation LifeSphere EasyDocs document management solution across the product lifecycle, the LifeSphere platform helps life sciences companies reduce time to market, increase compliance and lower drug development costs.
LifeSphere®
Clinical Development
LifeSphere®
Regulatory
LifeSphere®
Safety
LifeSphere®
Medical Affairs
LifeSphere®
Quality
LifeSphere®
EasyDocs
Delivering Real Results to a Global Client Base
Delivering Real Results to a Global Client Base
80%
of the top 50 pharma companies are our clients
30%
immediate cost saving potential via our advance automation capabilities
80%
potential efficiency gains driven by our Nava cognitive computing engine.
100%
compliance with all present and upcoming regulatory standards.
LifeSphere MultiVigilance 10
Intelligent and Automated Safety Platform for Individual Case Safety Report Processing
Working with Some of the Industry’s Best
Working with Some of the Industry’s Best
What Our
Customers are Saying
“Our decision to upgrade to LifeSphere Safety MultiVigilance was based on better integration, improved case management, reduced costs, and the ability to reach even higher compliance requirements of our customers and regulators.”
Ravi Menon
Chairman of the Board,
APCER Life Sciences
“Advanced technology, such as artificial intelligence and machine learning, are key LSMV capabilities that help us automate repetitive, manual tasks, thus improving efficiency and compliance. By switching to LifeSphere Safety MultiVigilance, our efforts to comply with regulations will be much more efficient.”
Fosun Pharma
“We have seen how the LifeSphere platform’s advanced robotic automation and cognitive features will allow us to automate many of our key PV steps in the area of case processing, which are currently resource intensive”
Claudia Lehmann
Head of PV Operations,
Boehringer Ingelheim
News
Press Release:
10 Life Sciences Companies Switch to ArisGlobal
ArisGlobal announces ten life sciences companies have switched from incumbent safety systems to LifeSphere® MultiVigilance.
Learn More
Press Release:
LifeSphere® LitPro
ArisGlobal Brings Complete, Automated Literature Monitoring Solution to Deliver Improved Pharmacovigilance
Learn More
Press Release:
LifeSphere® MultiVigilance 10
ArisGlobal Announces LifeSphere® MultiVigilance 10, Industry’s First End-to-End Safety System With Production-Ready Automation
Learn More
Press Release:
10 Life Sciences Companies Switch to ArisGlobal
ArisGlobal announces ten life sciences companies have switched from incumbent safety systems to LifeSphere® MultiVigilance.
Learn More
Press Release:
LifeSphere LitPro
ArisGlobal Brings Complete, Automated Literature Monitoring Solution to Deliver Improved Pharmacovigilance
Learn More
Press Release:
LifeSphere® MultiVigilance 10
ArisGlobal Announces LifeSphere® MultiVigilance 10, Industry’s First End-to-End Safety System With Production-Ready Automation
Learn More
Thought Leadership
White Paper
Regional Pharmacovigilance Regulations: Challenges with Non-Harmonized Regulatory Expectations
White Paper
Regional Pharmacovigilance Regulations: Challenges with Non-Harmonized Regulatory Expectations
The adoption of ICH E2B (R3) by regulatory authorities across the world represents a major evolution in pharmacovigilance data standards, but having the right safety system can provide major advances.
